- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC in the Press, November 18, 2016
A review of our peer-reviewed research in the healthcare and mainstream press.
MIT News cited an August study from The American Journal of Managed Care (AJMC) in an article about data-driven diabetes management. The AJMC study, “Association Among Change in Medical Costs, Level of Comorbidity, and Change in Adherence Behavior,” examined the costs of medication nonadherence for patients with diabetes and other conditions. A formerly nonadherent patient becoming adherent is associated with significant savings, which is why the MIT article is enthusiastic about a smart insulin-pen cap that sends usage data to an app.
An article about pain relievers in The Washington Post mentioned a 2013 AJMC study, “Quantifying the Impact of NSAID-Associated Adverse Events.” The Post article cited the study’s finding that half of seniors 65 years or older take at least 7 doses of nonsteroidal anti-inflammatory drugs (NSAIDs) per week.
Without IRA Fix, COA Warns Community Oncology Practices Will Shut Down
June 30th 2025Ted Okon, MBA, of the Community Oncology Alliance discusses how community oncology faces a revenue crisis due to the Inflation Reduction Act's impact on Medicare reimbursement, risking patient access to vital cancer treatments.
Read More
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
